Eli Lilly and Rigel Pharmaceuticals partnered in February 2021 to advance a pair of RIPK1 blockers, but the pharma in October ...

Eli Lilly and Company (NYSE:LLY) is one of the top S&P 500 stocks by index weight. On April 15, BMO Capital reiterated an ...

On April 15, 2026, Eli Lilly and Company (NYSE:LLY) reported topline results from the Phase 3 ACHIEVE-4 trial evaluating ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

A federal judge ruled Eli Lilly & Co. can proceed with its lawsuit against a business selling copycat versions of its obesity ...

Eli Lilly is picking up its second in vivo CAR-T company of the year, paying $3.25 billion in upfront cash for Kelonia ...

Kelonia is developing technology to reprogram patients' T-cells inside the body so those cells can attack cancer, called in ...

Two of the biggest insurance providers have expressed reluctance to participate in the government’s BALANCE program that ...

Eli Lilly is upgraded to Buy after a 13% pullback and strong Q4 guidance, with potential for 25% topline growth in 2026.

INDIANA – Today, Governor Braun signed a Letter of Intent with Eli Lilly and Company to collaborate on a future pathway for ...

Investors often mistake share price for valuation. While Eli Lilly's stock price looks expensive on the surface, the ...